Research programme: therapeutic agents - Astellas Pharma/MerLion Pharmaceuticals
Alternative Names: Therapeutic agents research programme - Astellas Pharma/MerLion PharmaceuticalsLatest Information Update: 19 Jan 2011
At a glance
- Originator Astellas Pharma; MerLion Pharmaceuticals
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Unspecified
Most Recent Events
- 11 Oct 2005 Early research in Undefined in Japan (unspecified route)
- 11 Oct 2005 Early research in Undefined in Singapore (unspecified route)